Given that miR-29b is downregulated in CML patients, it was chosen for further examination, demonstrating that the overexpression of miR-29b in the K562 CML cell line results in a reduction in BCR::ABL1 expression. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.